Virtual Symposium (CME concluded): Advances in Iron Repletion Therapy: Addressing the Burden of Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Iron deficiency (ID) affects up to one-third of the world’s population and is particularly common in elderly individuals and those with certain chronic diseases such as chronic kidney disease, and congestive heart failure. Many of those affected are unaware of ID and cannot recognize its symptoms. For patients with heart failure (HF), ID is an independent predictor of outcomes and a major contributor to exercise intolerance. At least half of all patients with HF have comorbid ID; yet, the condition is under-recognized and untreated in most patients.

In this symposium, experts will provide participants with data from recent and ongoing trials of iron repletion in patients with HF to highlight the importance of diagnosis and proper management of this common comorbidity. HF treatment guidelines that emphasize ID recognition and treatment will also be overviewed. Additionally, the program will educate clinicians on the differences in oral versus intravenous iron formulations.

Iron Deficiency in Heart Failure

Presenter: Gurusher S. Panjrath, MD, FACC, FAHA

Treatment of Iron Deficiency: Evidence from Recent and Ongoing Clinical Trials

Presenter: Biykem Bozkurt, MD, PhD, FACC, FAHA

Clinical Case Presentation and Discussion

Presenter: Andy Y. Lee, MD

Panel: All Faculty

Audience Q&A

Chairperson: Peter A. McCullough, MD, MPH

Panel: All Faculty